At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18,157 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections
In Brief
An observational study for Influenza, Human and 4 related conditions. Completed, enrolled 18,157 participants across 1 site.
Detailed Summary
The goal of this decentralized, observational study is to enroll and observe adults in the contingent United States during the 2023-2024 flu season. The main study objectives are to create a dataset of paired wearable data, self-reported symptoms, and respiratory viral infection (RVI) from PCR testing during the 2023-2024 flu season and to develop algorithm that is able to accurately classify asymptomatic and symptomatic RVI and understand the algorithm's performance metrics.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Timeline
N/ACompletedFinished
202420252026
First PostedJan 2024
Enrollment StartJan 2024
Primary CompletionAug 2024
TodayJul 2026
First PostedJan 17, 2024
Enrollment StartJan 21, 2024
Primary CompletionAug 7, 2024
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 2.5 years ago